5440092025-01-012025-03-315440092025-03-315440092024-03-315440092024-04-012025-03-315440092025-01-012025-03-31in-capmkt:OtherExpenses1Member5440092024-04-012025-03-31in-capmkt:OtherExpenses1Member5440092025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15440092024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15440092025-01-012025-03-31RelatedPartyTransactionDomain15440092024-12-31RelatedPartyTransactionDomain15440092025-03-31RelatedPartyTransactionDomain15440092025-01-012025-03-31RelatedPartyTransactionDomain25440092024-12-31RelatedPartyTransactionDomain25440092025-03-31RelatedPartyTransactionDomain25440092025-01-012025-03-31RelatedPartyTransactionDomain35440092024-12-31RelatedPartyTransactionDomain35440092025-03-31RelatedPartyTransactionDomain35440092025-01-012025-03-31RelatedPartyTransactionDomain45440092024-12-31RelatedPartyTransactionDomain45440092025-03-31RelatedPartyTransactionDomain45440092025-01-012025-03-31RelatedPartyTransactionDomain55440092024-12-31RelatedPartyTransactionDomain55440092025-03-31RelatedPartyTransactionDomain55440092025-01-012025-03-31RelatedPartyTransactionDomain65440092024-12-31RelatedPartyTransactionDomain65440092025-03-31RelatedPartyTransactionDomain65440092025-01-012025-03-31RelatedPartyTransactionDomain75440092024-12-31RelatedPartyTransactionDomain75440092025-03-31RelatedPartyTransactionDomain75440092025-01-012025-03-31RelatedPartyTransactionDomain85440092024-12-31RelatedPartyTransactionDomain85440092025-03-31RelatedPartyTransactionDomain85440092025-01-012025-03-31RelatedPartyTransactionDomain95440092024-12-31RelatedPartyTransactionDomain95440092025-03-31RelatedPartyTransactionDomain95440092025-01-012025-03-31RelatedPartyTransactionDomain105440092024-12-31RelatedPartyTransactionDomain105440092025-03-31RelatedPartyTransactionDomain105440092025-01-012025-03-31RelatedPartyTransactionDomain115440092024-12-31RelatedPartyTransactionDomain115440092025-03-31RelatedPartyTransactionDomain115440092025-01-012025-03-31RelatedPartyTransactionDomain125440092024-12-31RelatedPartyTransactionDomain125440092025-03-31RelatedPartyTransactionDomain125440092025-01-012025-03-31RelatedPartyTransactionDomain135440092024-12-31RelatedPartyTransactionDomain135440092025-03-31RelatedPartyTransactionDomain135440092025-01-012025-03-31RelatedPartyTransactionDomain145440092024-12-31RelatedPartyTransactionDomain145440092025-03-31RelatedPartyTransactionDomain145440092025-01-012025-03-31RelatedPartyTransactionDomain155440092024-12-31RelatedPartyTransactionDomain155440092025-03-31RelatedPartyTransactionDomain155440092025-01-012025-03-31RelatedPartyTransactionDomain165440092024-12-31RelatedPartyTransactionDomain165440092025-03-31RelatedPartyTransactionDomain165440092025-01-012025-03-31RelatedPartyTransactionDomain175440092024-12-31RelatedPartyTransactionDomain175440092025-03-31RelatedPartyTransactionDomain175440092025-01-012025-03-31RelatedPartyTransactionDomain185440092024-12-31RelatedPartyTransactionDomain185440092025-03-31RelatedPartyTransactionDomain185440092025-01-012025-03-31RelatedPartyTransactionDomain195440092024-12-31RelatedPartyTransactionDomain195440092025-03-31RelatedPartyTransactionDomain195440092025-01-012025-03-31RelatedPartyTransactionDomain205440092024-12-31RelatedPartyTransactionDomain205440092025-03-31RelatedPartyTransactionDomain205440092025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544009BLUEJETNOTLISTEDINE0KBH01020BLUE JET HEALTHCARE LIMITEDMain BoardEquity2024-04-012025-03-312025-05-142025-05-09INRMillionsQuarterlyFourth quarterSingle segmentPharmaceutical and API'S2025-05-1413:05:002025-05-1413:50:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-05-14https://bluejethealthcare.com/governance-policies/falsefalseThe Company has not made any default with respect to loan and debt securities2025-01-012025-03-31AuditedStandalone3404450000122250000352670000016348100000-10008000015992000034000049470000310120000205458000014721200000147212000036775000034200003711700000110095000000001100950000320000110127000034693000026.356.35006.356.351. The above financial results of the Company for the three months and year ended March 31, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on May 14, 2025. Further, the above financial results have been reviewed by the Statutory Auditor of the Company. <BR> 2. The company is engaged in manufacturing of Artifical Sweetener, Contast Media Intermediate, Pharma Intermediate, APIs used in Pharmaceutical and Healthcare products. <BR> 3.During the previous year, an incident at the Mahad facility resulted in a loss of damaged assets and compensation to employees aggregating to Rs 97.43 million, accounted for as an exceptional items by the company. <BR> 4. During the year ended March 31, 2025, the Company changed its method of depreciation from the Written Down Value (WDV) to the Straight-Line Method (SLM) based on the assessment of technical parameters of the said property plant & equipment, which indicates a more uniform consumption of economic benefits over time. Consequently, for the year ended March 31, 2025 and three months ended March 31, 2025 the depreciation expense is lower by and profit before tax is higher by Rs 144.35 million and Rs 35.87 million respectively. <BR> 5. The Company has received a demand notice under Section 156 of the Income Tax Act, 1961 amounting to Rs 1,933.86 million (including interest amounting to Rs 646.44 million) for the Assessment Years 2020-21 to 2023-24. During the earlier years, the company had provided for the tax amount of Rs 1,287.42 million in the books of accounts. The matter is currently under appeal before higher authorities . Based on legal advice, the Company believes it has a strong case both on jurisdictional grounds and on merits and accordingly no further provision is made for interest liabilty . <BR> 6. The results for the three months ended March 31, 2025 and March 31, 2024 are balancing figure between the audited financial statements for the financial year ended March 31, 2025 and March 31, 2024 respectively and published unaudited results for nine months ended December 31, 2024 and December 31, 2023 respectively. <BR> 7.The Company does not have any subsidiaries, associates, or joint ventures as on March 31, 2025. Consequently, the preparation of consolidated financial statements is not applicable. <BR> 8.The Board of directors have recommended a final dividend of Rs 1.2 per share of face value of Rs 2 each for the year ended March 31, 2025, which is subject to the approval of shareholders at the ensued Annual General meeting of the Company. <BR> 9. Current tax expense of quarter ended Mar 25 and year ended Mar 25 also include Rs 2.75 mn of tax provision related prior years 2024-04-012025-03-31AuditedStandalone102998500004625600001076241000054024500000-790240000609970000980000177890000130037000067014200004060990000040609900009677500004121000010089600000305203000000003052030000320000305235000034693000021098418000017.5917.590017.5917.59Other Operating Expenses310120000Other Operating Expenses13003700002596420000888840000002330000280000000000551400005514000005703100004115840000263924000018669200003495330000329790000868090000086660000664679000077344000010059470000001417531000034693000010984180000113311100001133111000000001652600001652600004696000072910000002851300000188700008716600008905300003186300001209160000188400001317000013179000002559070000002844200000141753100001. Other Non current asset inlcude Right of Use asset Rs 404.12 million <BR> 2. Other non current financial liability inlcude lease liability of Rs 165.26 <BR> 3. Other current financial liability inlcude lease liability of Rs 34.60960000-1340880000-16950500000-75950000000048388000000017789000000000-492800000511500000-10547000000-80670000227500000-271297000013480200000008903700000457650000000000003820000798800000000000000000000000520800000391070000-351830000000000000012080000173490000000-185570000-797500000-79750000409540000329790000Items that will not be reclassified to profit or loss420000420000Items that will not be reclassified to profit or loss42000042000010000010000000320000320000Blue Jet Healthcare Limited******Akshay B Arora******Key Management PersonnelRemunerationapproved1800000022500002250000Blue Jet Healthcare Limited******Shiven A Arora******Key Management PersonnelRemunerationapproved2610000024800002480000Blue Jet Healthcare Limited******Naresh Shah******Key Management PersonnelRemunerationapproved2000000018400004330000Blue Jet Healthcare Limited******Popat Kedar******Executive DirectorRemunerationapproved15300000250000Blue Jet Healthcare Limited******Akshay B Arora******Key Management PersonnelAny other transactionReimbursement of IPO expenses receivable from Promotersapproved24490000270100002520000Blue Jet Healthcare Limited******Shiven A Arora******Key Management PersonnelAny other transactionReimbursement of IPO expenses receivable from Promotersapproved78900008710000810000Blue Jet Healthcare Limited******Divya Sameer Momaya******Independent DirectorAny other transactionSitting feesapproved50000014000050000Blue Jet Healthcare Limited******Preeti Gautam Mehta******Independent DirectorAny other transactionSitting feesapproved4500001800000Blue Jet Healthcare Limited******Girish Paman Vanvari******Independent DirectorAny other transactionSitting feesapproved55000014000050000Blue Jet Healthcare Limited******Priyanka Yadav******Independent DirectorAny other transactionSitting feesapproved5000000Blue Jet Healthcare Limited******Divya Sameer Momaya******Independent DirectorAny other transactionDirector Commissionapproved150000150000270000Blue Jet Healthcare Limited******Preeti Gautam Mehta******Independent DirectorAny other transactionDirector Commissionapproved500000500000900000Blue Jet Healthcare Limited******Girish Paman Vanvari******Independent DirectorAny other transactionDirector Commissionapproved500000500000900000Blue Jet Healthcare Limited******Shiven A Arora******Key Management PersonnelAny other transactionSecurity Depositapproved039100003910000Blue Jet Healthcare Limited******Payal N Shah******Daughter of DirectorAny other transactionProfessional feesapproved42000006300000Blue Jet Healthcare Limited******Shiven A Arora******Key Management PersonnelAny other transactionRentapproved3910000700000700000Blue Jet Healthcare Limited******Kanga & Co.******Entities controlled by directorAny other transactionProfessional feesapproved22000000Blue Jet Healthcare Limited******Amruta Popat Kedar******Daughter of DirectorAny other transactionSalaryapproved260000070000Blue Jet Healthcare Limited******Karuppannan Ganesh******Key Management PersonnelAny other transactionSalaryapproved1187000080300006920000Blue Jet Healthcare Limited******Sweta Poddar******Key Management PersonnelAny other transactionSalaryapproved1690000160000140000122860000Auditedtruekkc and associates llptrue2027-07-31